256 related articles for article (PubMed ID: 21857436)
1. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
Little DG; Kim HK
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
[TBL] [Abstract][Full Text] [Related]
2. Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease.
Young ML; Little DG; Kim HK
Clin Orthop Relat Res; 2012 Sep; 470(9):2462-75. PubMed ID: 22270467
[TBL] [Abstract][Full Text] [Related]
3. Local administration of bone morphogenetic protein-2 and bisphosphonate during non-weight-bearing treatment of ischemic osteonecrosis of the femoral head: an experimental investigation in immature pigs.
Kim HK; Aruwajoye O; Du J; Kamiya N
J Bone Joint Surg Am; 2014 Sep; 96(18):1515-24. PubMed ID: 25232075
[TBL] [Abstract][Full Text] [Related]
4. Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.
Johannesen J; Briody J; McQuade M; Little DG; Cowell CT; Munns CF
Bone; 2009 Nov; 45(5):898-902. PubMed ID: 19446052
[TBL] [Abstract][Full Text] [Related]
5. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
Kim HK; Morgan-Bagley S; Kostenuik P
J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs.
Cheng TL; Murphy CM; Cantrill LC; Mikulec K; Carpenter C; Schindeler A; Little DG
Int Orthop; 2014 Jul; 38(7):1527-33. PubMed ID: 24389948
[TBL] [Abstract][Full Text] [Related]
7. Legg-Calve-Perthes disease: etiology, pathogenesis, and biology.
Kim HK
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S141-6. PubMed ID: 21857428
[TBL] [Abstract][Full Text] [Related]
8. Transtrochanteric rotational osteotomy for late-onset Legg-Calve-Perthes disease.
Nakashima Y; Kubota H; Yamamoto T; Mawatari T; Motomura G; Iwamoto Y
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S223-8. PubMed ID: 21857443
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and new strategies for the treatment of Legg-Calvé-Perthes disease.
Kim HK
J Bone Joint Surg Am; 2012 Apr; 94(7):659-69. PubMed ID: 22488623
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid improves femoral head sphericity in a rat model of perthes disease.
Little DG; McDonald M; Sharpe IT; Peat R; Williams P; McEvoy T
J Orthop Res; 2005 Jul; 23(4):862-8. PubMed ID: 16023001
[TBL] [Abstract][Full Text] [Related]
11. Salter osteotomy in Legg-Calvé-Perthes disease.
Thompson GH
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S192-7. PubMed ID: 21857438
[TBL] [Abstract][Full Text] [Related]
12. [Bisphosphonate treatment in osteonecrosis of the femoral head].
Nishii T; Hashimoto J; Yoshikawa H; Miki H; Sugano N
Nihon Rinsho; 2007 Nov; 65 Suppl 9():537-41. PubMed ID: 18161162
[No Abstract] [Full Text] [Related]
13. 3D MRI Quantification of Femoral Head Deformity in Legg-Calvé-Perthes Disease.
Standefer KD; Dempsey M; Jo C; Kim HKW
J Orthop Res; 2017 Sep; 35(9):2051-2058. PubMed ID: 27864891
[TBL] [Abstract][Full Text] [Related]
14. Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head.
Aya-ay J; Athavale S; Morgan-Bagley S; Bian H; Bauss F; Kim HK
J Bone Miner Res; 2007 Jan; 22(1):93-100. PubMed ID: 17166092
[TBL] [Abstract][Full Text] [Related]
15. Novel three-dimensional MRI technique for study of cartilaginous hip surfaces in Legg-Calvé-Perthes disease.
Pienkowski D; Resig J; Talwalkar V; Tylkowski C
J Orthop Res; 2009 Aug; 27(8):981-8. PubMed ID: 19405084
[TBL] [Abstract][Full Text] [Related]
16. Material properties of bone in the femoral head treated with ibandronate and BMP-2 following ischemic osteonecrosis.
Aruwajoye OO; Aswath PB; Kim HKW
J Orthop Res; 2017 Jul; 35(7):1453-1460. PubMed ID: 27564450
[TBL] [Abstract][Full Text] [Related]
17. Anti-Interleukin-6 Therapy Decreases Hip Synovitis and Bone Resorption and Increases Bone Formation Following Ischemic Osteonecrosis of the Femoral Head.
Ren Y; Deng Z; Gokani V; Kutschke M; Mitchell TW; Aruwajoye O; Adapala NS; Kamiya N; Abu-Amer Y; Kim HK
J Bone Miner Res; 2021 Feb; 36(2):357-368. PubMed ID: 33053220
[TBL] [Abstract][Full Text] [Related]
18. Use of bisphosphonates in orthopedic surgery: pearls and pitfalls.
Lozano-Calderon SA; Colman MW; Raskin KA; Hornicek FJ; Gebhardt M
Orthop Clin North Am; 2014 Jul; 45(3):403-16. PubMed ID: 24975766
[TBL] [Abstract][Full Text] [Related]
19. The role of bracing in Legg-Calve-Perthes disease.
Hardesty CK; Liu RW; Thompson GH
J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S178-81. PubMed ID: 21857435
[TBL] [Abstract][Full Text] [Related]
20. Legg-Calvé-Perthes disease in dogs: a comparison to human Legg-Culvé-Perthes disease.
Mickelson MR; McCurnin DM; Awbrey BJ; Maynard JA; Martin RK
Clin Orthop Relat Res; 1981 Jun; (157):287-300. PubMed ID: 7249458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
